Home » Topics » Disease categories and therapies » Gastrointestinal

Gastrointestinal
RSS

Salix reports promising clinical results for ulcerative colitis treatment

May 16, 1997

NIH announces prospective grant of licenses for IL-12 antibodies

May 16, 1997

Centocor reports results from Crohn's disease studies

May 14, 1997

Low-dose oral IFN-alpha + high-dose injectable IFN-alpha for hepatitis C

May 14, 1997

Data from U.K. phase III trial of Zacutex presented

May 13, 1997

Hepatoprotective effects of ET antagonist TAK-044

May 12, 1997

Orphan Medical's medicated chewing gum reduces stomach levels of H. pylori

May 9, 1997

Tanabe licenses T-0632 to Zeria

May 8, 1997

Neose Technologies initiates phase II trials with antiulcer drug

May 8, 1997

Preliminary clinical results for Lexirin

May 8, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 31, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...